Biomedical-Research
Biomedical-Research funding pages collect matching grants, scholarships, benefits, fellowships, and other programs from the FindMyMoney.App directory. Use this page to compare current opportunities, then verify deadlines and eligibility on the official source before applying.
RFA-HL-26-016: Catalyze Enabling Technologies and Transformative Platforms for HLBS Research (R33)
The National Heart, Lung, and Blood Institute's Catalyze R33 supports further development and rigorous validation of transformative, multi-use technologies and platforms relevant to heart, lung, blood, and sleep research. The next listed application due date is 2026-10-21.
RFA-OD-25-010: Resource-Related Research Projects for Development of Models and Related Materials for Studying Human Health and Diseases (R24 Clinical Trials Not Allowed)
NIH/ORIP’s NIH-wide R24 opportunity funds development and improvement of broadly useful biomedical models, methods, and biological materials that can serve multiple NIH Institutes and Centers across multiple organ systems.
Rita Allen Foundation Scholars Program, 2026–2027 Cycle: Up to $110,000 a Year for Five Years for Early-Career Cancer, Immunology and Neuroscience Investigators, With Letters of Inquiry Closing 3 September 2026
The Rita Allen Foundation Scholars program gives early-career biomedical investigators up to $110,000 a year for as long as five years, with nominations restricted to one candidate per invited institution, a letter of inquiry deadline of September 3, 2026, and a final application deadline of October 14, 2026 for grants starting September 2027.
Searle Scholars Program 2027: $450,000 Over Three Years of Unrestricted Research Support for 15 First-Year Assistant Professors in Biomedical Science and Chemistry
The Searle Scholars Program awards 15 new grants a year of $450,000 over three years to newly appointed tenure-track assistant professors in the biomedical sciences and chemistry, nominated by participating U.S. institutions, with applications for the 2027 competition due September 30, 2026.
Targeting RNA in Disease with Novel Technologies (TRDNT) Challenge 2026
Historical reference for the closed NIH TRDNT Challenge Phase I, which sought novel endogenous-RNA technologies and offered up to $500,000 in Phase I prizes; NIH lists later phases as anticipated rather than announced application rounds.
The NIDDK Disorders of Gastrointestinal Interoception Consortium Clinical Centers (DGIC) (RFA-DK-27-117)
NIH has issued a forecasted RFA to fund up to six GI interoception clinical research centers plus a scientific data center to expand mechanisms-based work on gastrointestinal motility and interoceptive dysfunction beyond gastroparesis.
UK Obesity Research Institute Full Application 2026: Up to £72 Million From MRC and the British Heart Foundation for One Seven-Year National Institute, Closing 19 November 2026
The Medical Research Council, co-funding with the British Heart Foundation, opened the full application stage for the UK Obesity Research Institute on 30 July 2026, offering a single director-led award of up to £72 million over an initial seven years for mechanistic biomedical research into obesity, with applications closing 19 November 2026 at 4:00pm UK time.
W. M. Keck Foundation Research Program: $1 Million to $1.3 Million Over Three Years for High-Risk Basic Science, With the New Single-Phase Application Closing 7 December 2026
The W. M. Keck Foundation has replaced its multi-stage concept-and-proposal process with a single-phase application on a six-month cycle, awarding typically $1 million to $1.3 million over three years for pioneering basic physical, life, and biomedical science at US STEM PhD-granting institutions, with each institution allowed up to three submissions per cycle.